See more funds from Franklin Templeton Inv Funds
See more funds in the Specialist sector
See more funds managed by: Evan McCulloch
Franklin Biotechnology A Fund Acc
Discount: 5.00%¹
Fund Overview |
|
|---|---|
| Unit Price |
102.63p
23/05/2012 |
| Standard Initial Charge | 5.00% |
| TQ Invest Discount | 5.00% |
| Initial Charge Through TQ Invest | 0.00% |
| Saving 2 | £564.00 |
| Annual Management Charge | 1.50% |
| Total Expense Ratio | 1.89% |
| Fund size | £12,650,000 |
| Usable in ISA | Yes |
Fund holding information
| Holding | Weighting |
|---|---|
| Gilead Sciences Inc | 8.52% |
| Celgene Corp | 7.92% |
| Biogen Idec Inc | 6.74% |
| Amgen Inc | 6.02% |
| Alexion Pharmaceuticals Inc | 5.37% |
| Questcor Pharmaceutical Inc | 3.24% |
| Vertex Pharmaceutical | 3.21% |
| Medivation Inc | 2.47% |
| Regeneron Pharmaceuticals Inc | 2.34% |
| Salix Pharmaceuticals Ltd | 2.14% |
| Sector | Weighting |
|---|---|
| Pharmaceuticals | 91.41% |
| Money Market | 8.38% |
| Health Care | 0.21% |
| Region | Weighting |
|---|---|
| North America | 86.69% |
| Money Market | 8.38% |
| Europe Ex Uk | 3.33% |
| Uk | 1.60% |
| Asset Type | Weighting |
|---|---|
| North American Equities | 86.69% |
| Money Market | 8.38% |
| European Equities | 3.33% |
| Uk Equities | 1.60% |
1Discount for an ISA investment through the Cofunds platform.
2Saving based on a typical ISA investment of £11,280.00 through the Cofunds platform.
Data provided by 
The value of this investment and the income from it can go down as well as up. Past performance should not be regarded as a guide to the future. The investment described may not be suitable for all recipients and this factsheet does not constitute personalised investment advice. No liability is accepted for any loss arising from errors or omissions.